| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/01/2013 | US8343971 Pharmacologically-active vanilloid carbamates |
| 01/01/2013 | US8343970 PDE10 inhibitors and related compositions and methods |
| 01/01/2013 | US8343969 Bromo-phenyl substituted thiazolyl dihydropyrimidines |
| 01/01/2013 | US8343968 Case of renin inhibitors |
| 01/01/2013 | US8343967 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 01/01/2013 | US8343966 Organic compounds |
| 01/01/2013 | US8343965 Compositions containing micronized tanaproget prepared by wet granulation |
| 01/01/2013 | US8343964 Indolic derivatives, their preparation processes and their uses in particular as antibacterials |
| 01/01/2013 | US8343963 Sulfamoyl-phenyl-ureido compounds and their use as medicament |
| 01/01/2013 | US8343962 Topical formulation |
| 01/01/2013 | US8343961 Substituted heterocyclic compounds |
| 01/01/2013 | US8343960 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
| 01/01/2013 | US8343959 N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
| 01/01/2013 | US8343958 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5-receptor antagonists |
| 01/01/2013 | US8343957 Therapeutic pyrazoloquinoline urea derivatives |
| 01/01/2013 | US8343956 Process for making a crystalline zilpaterol salt |
| 01/01/2013 | US8343955 Benzoxazepin PI3K inhibitor compounds and methods of use |
| 01/01/2013 | US8343954 Compositions and methods for inhibition of the JAK pathway |
| 01/01/2013 | US8343953 Pharmaceutical compounds |
| 01/01/2013 | US8343952 Prolyl hydroxylase inhibitors and methods of use |
| 01/01/2013 | US8343951 Volatile sulfide production inhibitor and method for inhibiting the production of volatile sulfide using the inhibitor |
| 01/01/2013 | US8343950 Quinazoline derivatives and methods of treatment |
| 01/01/2013 | US8343949 Stabilized compositions comprising a therapeutically active agent, and an oxidizing preservative |
| 01/01/2013 | US8343948 Medicament for preventing and/or treating mammary carcinoma, containing a steroidal aromatase inhibitor |
| 01/01/2013 | US8343947 Therapeutic treatment |
| 01/01/2013 | US8343946 Ecdysterone compounds |
| 01/01/2013 | US8343945 Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| 01/01/2013 | US8343944 Trisubstituted boron-containing molecules |
| 01/01/2013 | US8343943 Cancer sensitizer comprising glucosamine, glucosamine derivatives or salts thereof |
| 01/01/2013 | US8343942 Methods for treating interstitial cystitis |
| 01/01/2013 | US8343937 Methods and compositions for treating flaviviruses and pestiviruses |
| 01/01/2013 | US8343936 Antibacterial agents |
| 01/01/2013 | US8343935 Wound and skin care products |
| 01/01/2013 | US8343934 Diverse lead compound autotaxin inhibitors |
| 01/01/2013 | US8343927 Pharmaceutical compositions for prevention of overdose or abuse |
| 01/01/2013 | US8343926 Therapeutic strategies for prevention and treatment of alzheimer's disease |
| 01/01/2013 | US8343913 Hsp90, buffering and drug resistance |
| 01/01/2013 | US8343893 Substituted enaminocarbonyl compounds |
| 01/01/2013 | US8343763 Heterocyclic derivatives as modulators of ion channels |
| 01/01/2013 | US8343761 Methods of generating and using antibody-producing cells |
| 01/01/2013 | US8343557 Compositions incorporating agents for reducing cellulite and unaesthetic appearance associated therewith and formulations containing them |
| 01/01/2013 | US8343554 Formulations for the treatment of arthritis conditions |
| 01/01/2013 | US8343551 Nanocomposite particles |
| 01/01/2013 | US8343550 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 01/01/2013 | US8343549 Therapeutic uses of Dunaliella powder |
| 01/01/2013 | US8343544 Oral sustained-release tablet |
| 01/01/2013 | US8343543 Lipase inhibiting composition |
| 01/01/2013 | US8343540 Process for producing fenofibrate tablets |
| 01/01/2013 | US8343533 Manufacture of lozenge product with radiofrequency |
| 01/01/2013 | US8343519 Enhancing the efficacy of an active agent in or on the body, comprising applying to the body a combination of an active agent and at least one salicylic acid derivative |
| 01/01/2013 | US8343513 Mixture of polymer and drug with acid adjuvant |
| 01/01/2013 | US8343511 Methods and compositions for treating inflammatory bowel disease |
| 01/01/2013 | US8343478 Parapoxviruses in combination with other antiviral agents for the treatment of viral diseases |
| 01/01/2013 | US8343474 Substituted organopolysiloxanes and uses thereof |
| 01/01/2013 | US8343473 Hydrophilized antimicrobial polymers |
| 01/01/2013 | US8343472 Biodegradable polyurethane/urea compositions |
| 01/01/2013 | US8343471 Nanoparticulate in-situ gels of TPGS, gellan and PVA as vitreous humor substitutes |
| 01/01/2013 | US8343469 Cationic synthetic polymers with improved solubility and performance in surfactant-based systems and use in personal care and household applications |
| 01/01/2013 | US8343465 Cooling cosmetic or dermatological preparations comprising (1R,2S,5R)-2-isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl)-cyclohexane carboxamide and/or (1R,2S,5R)-N-(4-cyanomethyl-phenyl)-2-isopropyl-5-methylcyclohexane carboxamide for reducing skin reddening |
| 01/01/2013 | US8343084 Clotting cascade initiating apparatus and methods of use and methods of closing wounds |
| 12/28/2012 | CA2781269A1 Zinc oxide/acid containing compositions and methods for treating and/or preventing enzymatic irritation |
| 12/27/2012 | WO2012178208A2 Selective inhibitors of histone deacetylase isoform 6 and methods thereof |
| 12/27/2012 | WO2012178142A1 Ppar-sparing compounds and combinations fort the treatment of diabetes and other metabolic diseases |
| 12/27/2012 | WO2012178127A2 Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites |
| 12/27/2012 | WO2012178125A1 Compounds useful as inhibitors of atr kinase |
| 12/27/2012 | WO2012178124A1 Compounds useful as inhibitors of atr kinase |
| 12/27/2012 | WO2012178123A1 Compounds useful as inhibitors of atr kinase |
| 12/27/2012 | WO2012178122A2 Phenocopy model of disease |
| 12/27/2012 | WO2012178108A1 Prevention and treatment of inflammatory conditions |
| 12/27/2012 | WO2012178058A1 Compositions for and methods of detecting, diagnosing and prognosing thymic cancer |
| 12/27/2012 | WO2012178057A1 Compounds and methods of prophylaxis and treatment regarding nictonic receptor antagonists |
| 12/27/2012 | WO2012178038A1 Methods of treating cancer |
| 12/27/2012 | WO2012178036A2 Inhibitors of rtt109 as anti-fungal agents |
| 12/27/2012 | WO2012178022A2 Therapeutic applications targeting sarm1 |
| 12/27/2012 | WO2012178015A2 Lrrk2 inhibitors |
| 12/27/2012 | WO2012177925A1 Akt inhibitors for treating cancer expressing a magi3 - akt3 fusion gene |
| 12/27/2012 | WO2012177896A1 Trpm8 antagonists and their use in treatments |
| 12/27/2012 | WO2012177886A2 Process of forming crystals for use in a personal care composition |
| 12/27/2012 | WO2012177852A1 Substituted imidazopyridinyl compounds |
| 12/27/2012 | WO2012177847A2 Methods of dissolving blood clots and the like |
| 12/27/2012 | WO2012177844A2 Substituted imidazopyridinyl-aminopyridine compounds |
| 12/27/2012 | WO2012177842A1 Fast dissolving azaperone granulate formulation |
| 12/27/2012 | WO2012177835A1 Proteasome inhibitors and processes for their preparation, purification and use |
| 12/27/2012 | WO2012177831A2 Compounds for treating peripheral neuropathies and other neurodegenerative disorders |
| 12/27/2012 | WO2012177813A1 Pesticidal compositions and processes related thereto |
| 12/27/2012 | WO2012177799A1 Subcutaneous fat reduction |
| 12/27/2012 | WO2012177782A1 Compounds and therapeutic uses thereof |
| 12/27/2012 | WO2012177770A1 Bipartite inhibitors of bacterial rna polymerase |
| 12/27/2012 | WO2012177756A2 Non-leaching antimicrobial wound dressing |
| 12/27/2012 | WO2012177746A1 Methods of preventing or treating disease states related to certain metabolic abnormalities |
| 12/27/2012 | WO2012177741A1 Pcsk9-binding polypeptides and methods of use |
| 12/27/2012 | WO2012177738A1 Imidazole derivatives as inhibitors of pde10 |
| 12/27/2012 | WO2012177725A1 Metalloenzyme inhibitor compounds |
| 12/27/2012 | WO2012177714A1 Substituted 6-aza-isoindolin-1-one derivatives |
| 12/27/2012 | WO2012177708A1 Paliperidone oleate |
| 12/27/2012 | WO2012177707A1 Phosphate esters of gyrase and topoisomerase inhibitors |
| 12/27/2012 | WO2012177684A2 Use of caspase 3 activity and its inhibitors |
| 12/27/2012 | WO2012177678A2 Isotopologues of pomalidomide |
| 12/27/2012 | WO2012177658A2 Methods of treating and preventing staphylococcus aureus infections and associated conditions |
| 12/27/2012 | WO2012177640A2 Modulation of tissue transglutaminase activation in disease |